Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,304.00p
   
  • Change Today:
    -58.00p
  • 52 Week High: 1,750.00
  • 52 Week Low: 1,265.00
  • Currency: UK Pounds
  • Shares Issued: 228.88m
  • Volume: 344,074
  • Market Cap: £2,984.64m
  • RiskGrade: 134
  • Beta: 0.04

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Abcam completes earnings-accretive BioVision acquisition

By Josh White

Date: Wednesday 27 Oct 2021

(Sharecast News) - Science research tools company Abcam announced on Wednesday that it has completed its acquisition of BioVision from Boai NKY Medical Holdings, for total consideration of $340m.

Abcam to buy BioVision for $340m

By Michele Maatouk

Date: Monday 02 Aug 2021

(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m.

Avacta signs global distribution deal with Abcam

By Josh White

Date: Tuesday 06 Apr 2021

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a global distribution agreement with Abcam, it announced on Tuesday, to sell its recently-developed SARS-CoV-2 research 'ELISA Affimer' reagents.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,304.00p
Change Today -58.00p
% Change -4.26 %
52 Week High 1,750.00
52 Week Low 1,265.00
Volume 344,074
Shares Issued 228.88m
Market Cap £2,984.64m
Beta 0.04
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.38% below the market average76.38% below the market average76.38% below the market average76.38% below the market average76.38% below the market average
59.18% below the sector average59.18% below the sector average59.18% below the sector average59.18% below the sector average59.18% below the sector average
Price Trend
34.24% below the market average34.24% below the market average34.24% below the market average34.24% below the market average34.24% below the market average
12.9% below the sector average12.9% below the sector average12.9% below the sector average12.9% below the sector average12.9% below the sector average
Income Not Available
Growth
35.17% above the market average35.17% above the market average35.17% above the market average35.17% above the market average35.17% above the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 18-Jan-2022

Time Volume / Share Price
16:35 66,009 @ 1,304.00p
16:29 41 @ 1,305.00p
16:29 150 @ 1,305.00p
16:29 59 @ 1,304.00p
16:29 45 @ 1,304.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page